OMCL Omnicell Inc
Company Analysis
Latest News
🟢 Omnicell is trading 5% up today after BlackRock disclosed a 16.58% stake
Omnicell is trading at $34.76, up +5.08%, after BlackRock disclosed acquiring more than 7.5 million shares during the second quarter, creating a 16.58%...
BlackRock builds 16.58% Omnicell stake, following earnings beat
BlackRock Inc. acquired more than 7.5 million shares of Omnicell during the second quarter. This purchase establishes a 16.58% stake in the medication...
🟢 Omnicell is trading 7.2% up in after-hours trading with no clear company-specific catalyst
Omnicell is trading $40.00 (+7.24%) after rising sharply following the August 14, 2026 regular-session close, with no clear company-specific catalyst...
🟢 Omnicell is trading 5.63% up today amid a broad risk-on rally and easing geopolitical tensions
Omnicell is trading at $37.36 (+5.63%) following a broad risk-on move in U.S. equities and improving market sentiment. • The rally is supported by a stronger...
🔴 Omnicell is trading 5.04% down today as post-earnings selloff continues on cautious guidance
Omnicell is trading at $35.24 (-5.04%) as the stock extends losses following a sharp post-earnings selloff on July 30. • While the company reported 7% revenue...
🔴 Omnicell is trading 13% down today on soft recurring revenue outlook despite earnings beat
Omnicell is trading 13% down at $36.72 after its second-quarter earnings report, as concerns over recurring revenue trends outweighed a beat on the top and...
🔴 Omnicell is trading 10.1% down today after mixed Q2 earnings and lowered recurring revenue outlook
Omnicell is trading at $37.22 (10.1% down) following its second-quarter earnings report, which beat estimates but raised concerns regarding the quality and...
Omnicell Beat Estimates but the Market Isn't Buying It — Can a One-Time Windfall Mask a Slower Growth Story?
Shares plunged 7.7% to $38.22 this morning after Omnicell reported second-quarter 2026 results that looked strong on the surface — $312.2 million in revenue...
🔴 Omnicell is trading 7.7% down today as investors weigh profit quality and a one-time tariff refund
Omnicell is trading at $38.22 (7.7% down) following its second-quarter 2026 earnings release, as investors focus on the sustainability of profits despite a...
Omnicell's second quarter revenue grew 7% to $312M and EPS more than doubled, beating expectations.
Omnicell reported second quarter 2026 revenue of $312.2 million, an increase of 7% year-over-year, and non-GAAP EPS of $0.94, more than doubling from $0.45 in...
🔴 Omnicell is trading 6% down today as investors reposition ahead of Q2 earnings
Omnicell is trading 6% down at $40.46 as investors reposition ahead of the company’s Q2 2026 earnings report scheduled for July 30, 2026. • Traders appear to...
Omnicell Inc Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Omnicell is expected to report Q2 2026 revenue of $310.22 million and EPS of $0.48, with the current stock price of $43.05 trading significantly below the...
🔴 Omnicell is trading 5% down today on weak guidance and earnings miss
Omnicell is trading at $43.13 (down 5%) as the stock continues to face pressure following a recent earnings-driven selloff. • The decline follows a Q4 2025...
🟢 Omnicell shares gain 4.1% today as KeyBanc reiterates Overweight on Titan XT launch, boosting investor confidence
Omnicell is trading 4.1% up today at $46.76. • KeyBanc reiterated an Overweight rating and a $70 price target on OMCL today, citing the launch of its Titan XT...